Essential fatty acids (EFA) are the indispensable component of the lipid supply beyond the provision of energy as a fuel for oxidation. They serve as dietary precursors for the formation of prostanoids and other eicosanoids thus are of great signi®cance in health and modulation of disease conditions. Eicosanoids are powerful autocrine and paracrine regulators of cell and tissue functions: thrombocyte aggregation, in¯ammatory reactions and leukocyte functions, vasoconstriction and vasodilatation, blood pressure, bronchial constriction, and uterine contraction. Recent attention has focused on the effect of n-3 and n-6 long chain EFAs in normal fetal development. Results from human infant studies suggest that n-3 fatty acids are needed for optimal development of visual and brain function. Human milk is the best and only time proven source of fat and dietary essential fatty acids for infant feeding. International recommendations for n-3 and n-6 EFA dietary intake are reviewed and suggested intakes for long chain EFAs are provided.
Basis for essentiality of EFAs, dietary de®cit, structural and biochemical functional correlations and disease prevention
Dietary essential fatty acids (EFA) have long been considered part of the lipid supply necessary for energy, growth, cellular metabolism, and muscle activity. The fact that some EFAs serve as indispensable dietary precursors for eicosanoid formation has provided greater signi®cance to the study of their role in health and disease. During the past decade increasing attention has been placed on the effect of n-3 and n-6 EFAs in normal fetal and infant development (Sprecher, 1981; Bazan, 1989; Willis, 1984; Uauy & Hoffman, 1991; Simopoulos, 1991; Innis, 1991; Uauy et al, 1989) . Dietary fatty acid intake also affects cholesterol metabolism throughout the life cycle and is associated with cardiovascular morbidity and mortality.
Basis for nutritional essentiality of EFAs and derivatives
The concept that speci®c components of fat may be necessary for the proper growth and development of animals and possibly humans was introduced in the 1930s (Burr & Burr, 1929 ). Yet EFAs were considered of marginal importance until the 1960s when signs of clinical de®ciency became apparent in infants fed skim-milk-based formula and in those given lipid-free parenteral nutrition. The essentiality of n-6 and n-3 FAs for humans is best explained by the inability of animal tissue to introduce double bonds in positions prior to carbon 9.
Biochemical pathways for n-3 and n-6 FA desaturation are only present in chloroplasts. Terrestrial and marine plants and phytoplankton are the primary source of EFAs in the food chain; ®sh and other marine animals are able to elongate and desaturate the parent EFAs forming the long chain polyunsaturated fatty acids (LCPUFAs) (Sprecher, 1981; Willis, 1984; Simopoulos, 1991) . Animal tissues, especially the liver, are capable of further elongating and desaturating the parent EFAs generating families of compounds as shown in Figure 1 . As depicted in the ®gure, arachidonic acid [AA (20:4, n-6)] can be formed from linoleic acid [LA (18:2, n-6)]; thus it becomes essential only if the capacity for elongation and desaturation of linoleic acid is limited. This is the case in the cat and other felines. Further details on EFA metabolism can be found in recent reviews (Sprecher, 1981; Willis, 1984; Innis, 1991) . The competitive desaturation of the n-3, n-6 and n-9 series by delta-6 desaturase is of major signi®cance since this step is controlled by the interaction of hormones and diet including the amount of LA in the diet. Sprecher's group has further demonstrated that the formation of docosahexaenoic acid [DHA (22:6, ], initially thought to be catalyzed by a delta-4-desaturase, is indeed a 3-step process as depicted in Figure 1 . The initial step is an elongation, followed by delta-6 desaturation, and then, through a peroxisomal beta-oxidation, the chain is shortened to a 22 carbon PUFA. This latter step has been termed retroconversion (Voss et al, 1991) . The Sprecher pathway has now been veri®ed for both DHA and docosapentaenoic acid [DPA (22:5, ] formation. The delta-6 desaturase in the Sprecher pathway is probably different from the enzyme responsible for the initial step of the parent EFA metabolism. If n-3 FAs are absent or de®cient in the diet, the elongationadesaturation of the n-6 compounds generates a signi®cant elevation of DPA; if both EFAs are lacking eicosatrienoic acid [ETA (20:3, accumulates (Sprecher, 1981; Uauy & Hoffman, 1991; Innis, 1991) . The trieneatetraene ratio may be used as an index of essential fatty acid de®ciency but is not valid as a marker of isolated n-3 de®cit. In the latter case the ratio of DPA to DHA is a good marker.
The conversion of parent EFAs to long-chain PUFAs is under active regulation, therefore, the effects of providing AA, EPA or DHA cannot be reproduced by providing the equivalent amount of LA or LNA. The uniqueness of the biological effects of feeding human milk or marine foods on EFA metabolism is based on the direct supply of longchain PUFAs bypassing the controlling step of the delta-6 desaturase. Excess dietary LA associated with some vegetable oils, particularly saf¯ower, sun¯ower and corn oils, consumed in most western countries, may decrease the formation of DHA from a-linolenic acid [LNA (18:3, since the delta-6 desaturase is inhibited by excess substrate. In addition AA formation is lower when excess LA is provided (Sprecher, 1981; Willis, 1984; Simopoulos, 1991; Innis, 1991; Brenner & Peluffo, 1969) . The inhibitory effect of eicosapentaenoic acid [EPA (20:5, n-3)] on delta-5 desaturase activity has been considered responsible for the lower AA observed when marine oil is consumed. Excess LA, as seen in enterally or parenterally-fed patients receiving corn oil or saf¯ower oil as the predominant FA supply, will inhibit the elongationadesaturation of the parent EFAs, thus lowering the long chain PUFA supply necessary for membrane synthesis. Marine PUFAs provide minimal preformed AA and substantial amounts of preformed n-3 long-chain PUFA such as EPA and DHA (Brockerhoff et al, 1963) . Figure 2 summarizes trends in the consumption patterns of fats over the last two centuries. Saturated fats from animal foods, trans fats from hydrogenated vegetable and marine oils, and n-6 fatty acids from oil seeds have all increased, while n-3 fatty acids derived from plant and marine foods have declined. The ratio of n-6 to n-3 fatty acids in the western diet has increased.
The ratio of LA to LNA in the diet is an important factor in de®ning the capacity to biosynthesize AA and DHA. The biological equivalence of LNA relative to DHA, that is, how much LNA needs to be given to have a similar effect as compared to the direct provision of DHA, is variable depending on the level of LA in the diet, total energy supply and provision of other fatty acids. Studies from India based on several biological responses suggest that when LA intake is around 5% of total energy, 10% of LNA is converted to n-3 LCPUFA (Indu & Ghafoorunisa, 1992) . Emken et al (1994) using stable-isotope-labeled LNA demonstrated in human adults that when LA intake was increased from 4.7 ± 9.3% of energy, conversion of LNA to n-3 LCPUFAs was reduced by 50%. In human infant studies, the biological responses to DHA supplementation have not been fully reproduced by LNA supplementation in terms of concentrations of DHA in plasma and red cell phospholipids. In some cases equivalence in functional responses has been achieved, while in other studies this has not been possible. No conclusive data on this issue is available from isotopic studies in infants. At very low LAaLNA ratios the supply of LA may in fact be limiting, therefore restricting the use of this strategy to optimize LNA conversion to long-chain n-3 PUFAs. Other dietary factors such as overall energy and protein supply, as well as zinc and copper de®ciency, affect EFA metabolism; for example zinc de®cit is associated with decreased activity of delta-6 desaturase, thus low AA and DHA. Hormones such as insulin increase conversion of EFA to long-chain derivatives (Innis, 1991; Brenner & Peluffo, 1969) .
The fetus and the placenta are fully dependent on maternal EFA supply for normal growth and development. The diet before pregnancy plays an important role in determining maternal EFA status since these essential nutrients are stored in adipose tissue and can be mobilized over time. The major EFA deposition in the human fetus occurs during the third trimester; phospholipids in placental vessels and uterine vasculature are dependent on EFA supplied by the mother for eicosanoid formation. Maternal preconceptional nutrition determines, in part, which speci®c fats accumulate in the conceptus and placental tissues (Sprecher, 1981; Galli & Socini, 1983; Ongary et al, 1984) . Placenta takes up preferencially LCPUFA by a plasma membrane fatty acid-binding protein located in the microvillous membrane, so LCPUFA are in higher concentration in the fetus than in the mother (Dutta-Roy, 1997) .
The dry weight of the human brain is predominantly lipid. Studies in several animal species and recent evidence Figure 2 Trends in fatty acid consumption patterns over the last two centuries. Saturated fats from animal foods, trans fats from hydrogenated vegetable and marine oils, and n-6 fatty acids from oil seeds have all increased while n-3 fatty acids derived from plant and marine foods have declined. The ratio of n-6 to n-3 fatty acids in the western diet has increased. Figure 1 Metabolic transformation of essential fatty acids (EFA) to form long chain polyunsaturated fatty acids (LCPUFA). Parent EFAs are derived from dietary sources for both n-3 (18:3, a-linolenic acid) and n-6 series (18:2, linoleic acid). De novo synthesis is able to produce only n-9 LCPUFAs. Elongation occurs two carbons at a time and delta desaturases (D-9,-6,-5) introduce double bonds at 9, 6, and 5 carbons from the carboxylic moiety. The ®nal step in the formation of n-3 and n-6 endproducts is catalyzed by a peroxisomal partial beta-oxidation. PUFAs of interest include 18:3, n-6 gamma linolenic acid (GLA), arachidonic acid 20:4, n-6 (AA), docosapentaenoic acid 22:5, n-6 (DPA), eicosatrienoic acid 20:3, n-9 (ETA), eicosapentaenoic acid 20:5, n-3 (EPA) and docosahexaenoic acid 22:6, n-3 (DHA). EPA, AA and 20:3, n-6 are immediate precursors of prostaglandins (PG) and other eicosanoids.
Essential fatty acids R Uauy et al S67 from humans have established that brain phospholipid DHA decreases while n-9 and n-7 mono-and polyunsaturated fatty acids increase when LA and LNA or only n-3 fatty acids are de®cient in the diet (Galli et al, 1971; Menon & Dhopeshwarkar, 1982; Bourre et al, 1989a) . Typically, n-3 fatty acid de®cient cells have decreased DHA and increased levels of the end products of n-6 metabolism, docosapentaenoic acid (DPA). Within the subcellular organelles, synaptosomes and mitochondria seem to be more sensitive to a low dietary n-3 supply (Menon & Dhopeshwarkar, 1982; Bourre et al, 1989b) .
The high concentrations of long-chain derivatives of EFAs in cerebral cortex and retina suggest their participation in neural and visual function. The n-3 endproduct DHA reaches levels of up to 40% of total FAs in the phospholipids of these tissues (Bazan, 1989; Widdowson & Dickerson, 1981; Clandinin et al, 1980) . In the human, Clandinin et al (1980) have shown signi®cant increases in the AA and DHA content of brain tissue during the last trimester of gestation. More recently Martinez (1992) , using improved methodology, has provided complementary data on retinal and brain accretion of LCEFA.
The potential for dietary EFA de®ciency has become an important issue in the nutrition of preterm infants since these do not receive the third trimester intrauterine supply of DHA and AA. Even full term infants are potentially at risk of DHA de®ciency since most formulas are devoid of this critical EFA. Recent investigations have demonstrated that term infants who died suddenly, without a clear explanation, present a diet-dependent fatty acid composition of their brain cortex. Infants who were breastfed had higher DHA and lower DPA and AA in their cortex phospholipids than infants having received cow's milkbased formulas (Farquharson et al, 1992; Makrides et al, 1994) . DHA content increases with advancing age in breast-fed infants and is proportional to the duration of human milk feeding, while AA content remains stable. Furthermore the dietary ratio of n-6 to n-3 fatty acids appears relevant as the lowest DHA and highest DPA contents in brain cortex phospholipids were observed in preterm infants fed formulas with a high LA to LNA ratio (Makrides et al, 1994) .
Studies in rodents and non-human primates have characterized the biochemical and functional effects of dietary n-3 de®ciency (Wheeler et al, 1975; Watanabe et al, 1987; Neuringer et al, 1984 Neuringer et al, , 1991 . The animal models used puri®ed LA as the only dietary fat or saf¯ower or sun¯ower oil in which the n-6an-3 FA ratio (approximately 250:1) is very high (Neuringer et al, 1984 (Neuringer et al, , 1991 . High n-6an-3 FA ratios are found in powdered infant formulas currently in use in some parts of the world Hansen, 1993) . If these diets are fed from conception andaor during early life, signi®cant declines in DHA levels and elevations of DPA content of brain, retina and of other tissues occur in animals. Similar data have been obtained from plasma, red blood cell (RBC) lipids in preterm human infants fed corn-oil-based formula with a high LAaLNA ratio .
The measurement of the fatty acid composition of RBC lipids as a potential index of EFA status in retinal membranes is based on the observed correlations between fatty acid pro®les in RBCs and neuralaretinal tissue from rats, non-human primates, and human infants (Makrides et al, 1994; Carlson et al, 1986; Connor et al, 1993 ). Yet these correlations are not always signi®cant.
Structural role of EFAs and derived compounds
The implications of compositional changes in structural lipids have been extensively studied (Wheeler et al, 1975; Bourre et al, 1989c; Stubbs & Smith, 1984) . Membrane physiologists have suggested that the fatty acid composition of structural membrane lipids can affect membrane function by modifying overall membrane¯uidity, by affecting membrane thickness, by changing lipid phase properties, by speci®c changes in the membrane microenvironment, or by interaction of fatty acids with membrane proteins (Wheeler et al, 1975; Stubbs & Smith, 1984; Lee et al, 1986) . The changes in neural membranes that are of greatest potential signi®cance to humans, are changes affecting physical properties and membrane excitability (Wheeler et al, 1975; Bourre et al, 1989c; Stubbs & Smith, 1984; Lee et al, 1986) .
Multiple studies have shown that a de®ciency of essential fatty acids can change physical properties of membranes including membrane-bound enzymes, receptor activity, antigenic recognition, and signal transduction (Stubbs & Smith, 1984; Lee et al, 1986; Salem et al, 1988) . Also, n-3 fatty acid de®ciency affects rotational mobility, as measured by¯uorescent diphenylhexatriene probes, less than lateral mobility, as measured by pyrene dimer formation within the lipid bilayer (Stubbs & Smith, 1984; Lee et al, 1986; Salem et al, 1988; Treen et al, 1992) . We have found that excited dimer (eximer) pyrene formation in human retinal cells, which occurs when two pyrene monomers collide, is increased by DHA supplementation of the culture media (Treen et al, 1992) . Membrane composition changes in human retinoblastoma and neuroblastoma cell lines also affect membrane transport mechanisms (Treen et al, 1992; Yorek et al, 1984) . A higher DHA content increases the af®nity and transport rates for choline and taurine (Treen et al, 1992; Yorek et al, 1984) . Furthermore, preliminary studies suggest that the dietary n-3 fatty acid supply may affect nucleotide cyclase activity and rybosylation of guanine nucleotide binding proteins (Ahmad et al, 1990) .
Most dietary n-3 fatty acid-induced membrane changes are not re¯ected by an overall change in membrane¯uidity but rather result in selective changes in membrane microenvironment affecting speci®c domains. The replacement of DHA by DPA usually results in the same overall lipid unsaturation level. Thus¯uidity on average would remain unchanged. Furthermore, the main changes in the physical state, induced by changes in the fatty acid composition of lipid bilayers, occur after the ®rst and second double bonds are introduced; namely when a saturated fatty acid such as stearic acid (18:0) is replaced by oleic acid (18:1, n-9) or by linoleic acid (18:2, n-6) (Treen et al, 1992; Yorek et al, 1984) . Others have suggested that DHA supply modi®es the phospholipid molecular species present in neural tissues and also gene expression, therefore possibly affecting overall function (Lin et al, 1990; Clarke & Jump, 1993) . Recently Litman & Mitchell (1996) have reported that LCPUFAs present in membrane phospholipid molecular species have profound effects on G protein activation and related structural modi®cations. The rhodopsin MI 6 MII equilibrium constant is six times higher with di DHA acylated phosphatidyl choline (PC) than with di myristic PC, the di DHA PC having an equilibrium constant that is almost identical to that of native rod disks. The effect is mostly explained by the increase in membrane free volume. This greater mobility within the rhodopsin Essential fatty acids R Uauy et al microenvironment most likely explains the change in G protein activation and the corresponding enhanced signal transduction to photon stimuli (Litman & Mitchell, 1996) . Diet-induced changes in structural lipids affect the functional characteristics of excitable membranes in several animal species and in human neural cell lines (Wheeler et al, 1975; Neuringer et al, 1984; Bourre et al, 1989b; Love et al, 1985; Holh & Rosen, 1987) . Electrocardiographic abnormalities, such as a notching in the QRS complex, indicating impaired electrical conduction, occur in linoleic and a-linolenic acid de®ciency before clinical signs appear (Caster & Ahn, 1963) . Either linoleic or a-linolenic acid corrected these abnormalities. More recently, it has been shown that dietary fat in¯uences the susceptibility to cardiac arrhythmias, their incidence and severity (Charnock, 1991) . Furthermore, studies with myocardial preparations have indicated that the vulnerability to catecholamine-induced arrhythmia is reduced in animals fed either n-6 or n-3 PUFA-enriched diets (Abeywardena et al, 1987) . Feeding ®sh oil from blue®n tuna rather than sun¯ower oil and saturated fat resulted in a marked reduction in induced arrhythmias in two animal species and in isolated papillary muscle (Charnock, 1991) . Changes in cardiac electrophysiologic responses to beta-mimetics and reduced excitability of cardiac myocytes and in the susceptibility to arrhythmias have also been noted (Hallaq et al, 1992; . Myocytes form minimal amounts of cycloxygenase products and no lipoxygenase products, thus the changes in excitability and conduction are probably related to structural lipid composition, and re¯ect changes in the function of ion channels (Holh & Rosen, 1987) . N-3 fatty acid supplementation ameliorates the¯uidifying effect of ethanol on neural membranes while linoleic and a-linolenic acid de®ciency potentiates volatile anesthetic action in rats; linoleic acid supplementation speci®cally reverses this effect (Evers et al, 1986) .
The role of membrane lipid composition in determining the electrical properties of cultured neuronal cells exposed to exogenous fatty acids has been investigated (Lin et al, 1990; Love et al, 1985) . Both n-3 and n-6 fatty acids induced slower rates of rise, and to a lesser extent a lower amplitude, of Na action potentials. The opposite effects were observed when saturated or trans monoenoic fatty acids were added. It seems likely that these effects were mediated by a change in the number of active Na channels. A change in membrane composition or altered fatty acid availability to the cells could have caused this event (Love et al, 1985) . Eicosanoid production is another mechanism by which the effect of n-3 fatty acid supplementation on neural function could be explained. Phospholipases liberate AA, EPA, and DHA from membrane lipids and make them available to cycloxygenase or lipoxygenase action for production of eicosanoids (Holh & Rosen, 1987) .
Models to study the effect of EFAs in`healthy' humans
Fat-free parenteral nutrition as a model to study the effect of EFA de®ciency The fact that the use of TPN initially did not include lipids, permitted to con®rm the characteristic acute effects on the skin (Caldwell et al, 1972) and, of greater interest, the longterm effects of EFA de®ciency on sleep organization (Fagioli et al, 1989) . Studies in children maintained on fat-free TPN for 2 ± 6 months served to demonstrate consistently reduced duration of slow-wave sleep compared with children who received TPN plus essential lipids. The main difference was a lower cumulative amount of slowwave sleep time from the second hour of night-sleep onwards. These results suggest that early lipid nutrition may modulate sleep regulation and may have implications for whole body energy expenditure during sleep, since slow-wave sleep is associated with a lower metabolic rate than other stages of sleep (Stother & Warner, 1977) . Interestingly, no signi®cant difference was found in either total sleep time or intra-sleep waking in the EFAde®cient group. Alterations in sleep-wake cycle development may become evident only if the methods used include evaluations that are more subtle than total sleep or waking time measures. The possibility that fat-free TPN affected structural brain lipids is suggested by these results. In addition the excess LA relative to LNA in lipids used in parenteral nutrition has also been reported to affect brain fatty acid composition of infants receiving intravenous lipid emulsions in early life. Higher linoleic and lower DHA content in brain phospholipid fractions have been reported. The functional effect of this has not been studied (Martinez, 1992) .
Studies in preterm infants with controlled EFA intake Very-low-birth-weight (VLBW) infants are particularly vulnerable to de®ciency given the virtual absence of adipose tissue stores at birth. This de®ciency may be attributable to a possible immaturity of the FA elongationadesaturation pathways and the inadequate LNA and DHA intake provided by formula. We and others conducted studies to evaluate the effect of n-3 FA in VLBW infants examining the effects of LNA or LNA plus DHA supplementation on plasma and tissue lipid composition, retinal electrophysiologic function, maturation of the visual cortex and measures of infant growth and development Uauy et al, 1990; Carlson et al, 1991; Carlson et al, 1993; Birch et al, 1992a Birch et al, , 1992b .
Infants fed the n-3 FA-de®cient formula, in all studies, had signi®cant reductions in DHA of plasma and red cell lipids compared to the groups on other formula Uauy et al, 1990; Carlson et al, 1991; . DHA-supplemented infants presented higher DHA concentrations than those provided LNA but no DHA. In most studies where a human milk fed group has been used as a reference, the DHA AA-supplemented group has matched the LCPUFA blood levels of human milk fed infants. Initial studies used marine oil, which contains high EPA, as a source of LCPUFA; this lead to drops in AA, which in one study was signi®cantly associated to poor growth (Carlson et al, 1993) .
The functional measures of neurodevelopment have consistently shown delayed retinal maturation in the DHA-de®cient groups up to 40 weeks post-conceptional age; early differences in rod photoreceptor function disappeared after this time (Uauy et al, 1990; Birch et al, 1992a) . Retinal function responses demonstrated signi®-cantly higher threshold values in rod photoreceptors in the n-3 de®cient group indicating that the sensitivity and maturity of the rod photoreceptors in n-3 FA-de®cient infants were reduced signi®cantly compared to infants fed DHA-supplemented formula or human milk. Small differences in indices of inner retinal function (oscillatory potentials) persist for up to four months postnatal age Essential fatty acids R Uauy et al (Birch et al, 1992a) . Visual acuity measurements using forced choice preferential looking (a behavioral assessment) and visual evoked potentials (an electrophysiologic test) reveal that LPCUFA-supplemented infants are similar to human-milk-fed prematures in terms of acuity maturation, while the n-3 de®cient, even if provided ample LNA, have delayed maturation over the ®rst four months of postnatal life (Birch et al, 1992b) . Figure 3 summarizes some of our results on the effect of dietary EFA supply on indices of visual maturation (Birch et al, 1992a (Birch et al, , 1992b .
Cognitive development measures using preferential looking novelty response and Bayley psychomotor development testing are not conclusive. The interaction with enviromental and parental socioeconomic factors limits the capacity to detect potential diet-induced differences. In addition most studies have lacked the necessary sample size to detect differences which may be of small magnitude. Shorter look duration in the novelty response has been reported, but the interpretation of these ®ndings remains controversial .
Some issues regarding LCPUFA provision to preterm infants that require further research include: (1) The need to supplement both DHA and AA, or DHA alone, and whether other related fatty acids that are easier to obtain could substitute them; (2) The optimal amount of LCPUFA to include in the formula given that human milk is variable in DHA and AA content; (3) The duration of supplementation for optimal effects; (4) Possible effects of supplementation on prevalence of common neonatal morbidities, such as necrotizing enterocolitis and bronchopulmonary dysplasia; and (5) What sources of LCPUFAs should be used considering safety and costs.
Studies in term infants fed EFA-controlled diets
We conducted a 3 y follow-up of healthy, full-term infants to test if human milk feeding, which contains signi®cant amounts of DHA, had an effect on the development of visual function (Birch et al, 1993) . The cohorts were breastfed from birth to at least 4 months or fed for 12 months formula containing ample LA and 0.5% of the total fat as LNA. The breast-fed group was weaned to an oleic acid (18:1)-predominant formula and received egg yolk through 12 months of age. The breast-fed group maintained higher plasma and RBC membrane phospholipid DHA concentrations throughout the ®rst year of life. At 3 y of age, stereo acuity, as measured by operant preferential looking (OPL) techniques, was more mature in the breast-fed than in the formula-fed group; 92% of the breast-fed group had mature OPL stereo acuity whereas 35% of the infants in the formula-fed group met the maturity criteria. Visual recognition in the breast-fed group was also better; only 61% of the formula fed infants had a perfect score, as compared to 93% in the breast-fed group (Birch et al, 1993) . These and other complementary data from comparisons of infants who were breast fed with others who where given formula with ample LNA but devoid of LCPUFAs reported by Makrides et al (1993) and by Jorgensen et al (1996) suggested a breast milk, possibly DHA, effect on visual acuity maturation in term infants. One study showed a transient bene®t of breast milk: better visual acuity at two months . Some studies have attempted to optimize LNA to DHA conversion by providing suf®cient LNA (b 0.7% of total energy) and a lower LA to LNA ratio in formula (`10:1). Initial results by Ponder et al (1992) indicated that this alternate strategy could be simpler and less expensive than the addition of n-3 LCPUFA. Studies by Innis et al (1994 Innis et al ( , 1996 Innis et al ( , 1997 concluded that the need for DHA supplementation should not be based on the alleged improved visual acuity of breast fed infants since despite differences in DHA content in blood no differences in preferential looking acuity between BF and unsupplemented formula fed infants were found. The formula used in this study contained 2.1% of total fat as LNA but no LCPUFAs. A controlled randomized study using a formula supplemented with 0.36% DHA and compared with a formula providing ample LNA but no DHA and a breast fed reference group revealed delayed visual acuity at four and six months of age in the group on formula lacking DHA (Makrides et al, 1995) . On the other hand a recently published multicenter trial using formula supplemented with 0.2% DHA and 0.4% AA did not show an effect of this level of supplementation on visual acuity (Auestad et al, 1997) . A bene®cial effect of DHA, AA and GLA supplementation on psychomotor development at four and 12 months assessed by the Brunet-Lezine method has been reported (Agostoni et al, 1996) , yet 1 y is too early to predict future mental development in a consistent manner. Small effects of supplementation on weight-for-height have been reported in some studies; the relevance of these ®ndings remains to be determined (Jensen et al, 1997) . As discussed later, LCPUFA supplementation may have potential long-term effects on weight by regulating the expression of genes responsible for adipocyte development. Recent evidence indicates n-3 supplementation in the form of perilla oil given to rats after weaning signi®cantly reduces the growth of visceral adipose tissue despite similar total food consumtion. The epididymal fat pad weight was lower in the n-3 supplemented relative to olive oil or beef Figure 3 Effect of early diet on visual maturation responses. Rod ERG threshold at 36 weeks postconceptional age, visual evoked potential (VEP) and forced-choice preferential looking (FCPL) visual acuities of preterm study infants at 57 weeks postconceptional age. Rod ERG threshold is the light intensity (scotopic troland-seconds) required to induce a b-wave amplitude of 2mV, higher thresholds are associated with lower photoreceptor sensitivity. DHA supplementation decreases threshold mimicking the human milk fed group. Larger log minimum angle of resolution (logMAR) visual acuity values are associated with poorer visual acuity. Bars within a functional measure having an asterisk (*) are signi®cantly different from human milk fed group. LA, linoleic acid present in corn oil is the precursor of the n-6 EFAs, LNA, a-linolenic acid present in soy oil is the precursor of the n-3 EFAs, marine oil containing formula provided LNA and DHA the long chain derivative of LNA. Data from Birch et al (1992a,b) .
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R Uauy et al tallow fed groups. The expression of genes responsible for late adipocyte differentiation, adipsin, adipocyte P2 and peroxisome-activated receptor alpha where all down-regulated in the perilla oil fed group (Masataka et al, 1997) . This summary of results must lead to a re¯ection on several issues: the biological signi®cance of the effects, the selection of outcome measures, the duration and reversibility of the change and ®nally the long-term consequences of the effect. The presence of an effect does not in itself make it clinically signi®cant. For example, diet-induced changes in triglyceride composition are of little consequence except to validate compliance with a particular diet. Tissue fatty acid pools, particularly those required for retinal and CNS neural membrane formation, may not be re¯ected by plasma or even red cell fatty acid composition. Biochemical effects can not by themselves be used as surrogates for functional measures.
Another relevant issue is the selected outcome measure. Ideally it should be clinically relevant, but the sensitivity of clinical responses is usually low, therefore functional responses are considered valid to de®ne biologically signi®cant outcomes. In the case of LCPUFA supplementation, growth is affected only in extreme n-6 fatty acid de®ciency therefore is not considered a sensitive measure of n-6 suf®ciency. The effect of n-3 fatty acids on sensory maturation and cognitive development are the outcomes of greater interest in studies of n-3 supplementation.
The duration and reversibility of diet-induced effects is another important issue. There may be transient effects that re¯ect the acceleration or the slowing of a maturational process with a fully normal ®nal outcome. This is of special relevance during the ®rst few months of life when visual maturation is progressing rapidly. Several studies have demonstrated signi®cant effects of the dietary LCPUFAs on visual maturation in the ®rst four months of life, but in most cases the delayed response becomes normal at six months or at most by 1 y of age. Should we dismiss this phenomenon as transitory and of limited signi®cance or assume that we failed to detect a signi®cant change at 1 y because our tools were not sensitive enough, or that in fact other related function are indeed affected? Using this same example, we failed to detect differences in visual acuity at six months but depthaspatial perception assessed by stereoacuity responses were different at 3 y of age, as shown by our studies comparing breast fed to routine formula fed infants. These examples illustrate that unless sensitive outcome measures are used and suf®cient followup time is provided, it is impossible to fully discard the possible long-term consequences of early developmental effects.
Evidence of potential bene®cial long-term effects of LCPUFA supplementation on brain development of term infants is suggestive, proof is lacking. The resolution of this issue should be forthcoming, the follow-up of term infants included in the controlled clinical trials of DHA AA supplementation into the school age period should help to address the question of long-term effects (Dobbing 1997 ).
Studies of essential fatty acid metabolism using labeled precursors We and others have also conducted studies using labeled EFA precursors (Salem et al, 1996; Sauerwald et al, 1996) . Our stable isotope studies have used as a label 5 deuterated atoms distributed in the ®rst (n-1) and second (n-2) carbon atoms of the fatty acid chain (d5-LA and d5-LNA) to evaluate the conversion of these into LCPUFA (Salem et al, 1996) . Concentration of deuterated precursors and products were measured in plasma using negative ion mass spectrometry of penta¯uorobenzyl derivatives. Peak concentrations of labeled precursor EFAs were reached during the ®rst day after dosing, deuterated products increased concentrations with time reaching peak levels for the n-6 metabolites by 48 h in the term infants and closer to 96 h in the preterm SGA or AGA infants. For the n-3 series, concentrations of elongatedadesaturated products increase with time reaching highest levels in the term infants by 48 h; for preterm infants peak levels are reached by 96 h. The rise in labeled products for SGA infants is slower than that for AGA preterm infants. Other studies using uniformly labeled 13 C con®rm that preterm and term neonates are able to elongate and desaturate parent EFAs (Sauerwald et al, 1996; Carnielli et al, 1996) . Estimation of pool size, relevant precursor pool enrichment, knowledge of homogeneity in distribution in one or more pools and information on rates of oxidation of precursors and products are lacking in these studies. Therefore, they have not been able to provide quantitative information on synthetic rates in order to orient dietary recommendations. Earlier studies in adults have also documented n-3 LCPUFA formation from labeled LNA but no conversion of LA to arachidonic was documented (Emken et al, 1992) . El Boustani et al (1989) reported delta 5 desaturation and arachidonic acid formation in four human adults using deuterated 20:3, n-6. More recently Emken et al (1997) evaluated the in¯uence of AA on delta 5 desaturation concluding that AA supplementation in adults increased Dihommo GLA (20:3, n-6) turnover and desaturation into AA.
Studies in malnourished infants
Low-fat diets are a frequent cause of primary malnutrition in infants and children in developing countries. In addition these diets are of low energy density and therefore limit the total energy a child is able to consume in a single meal. There is very limited data on EFA composition of local diets used to feed infants as well as on EFA status of malnourished infants. If children are not breast fed most likely they will receive insuf®cient EFAs unless they are given appropriate complementary foods. Cereals are low in fat and most oil seeds will provide only parent EFAs LA rich and LNA poor, unless soy or rapeseed oil are available. Starchy roots, tubers and starchy fruits used as traditional complementary foods are low in fat and low in EFAs. Powdered cow milk used as a source of high quality protein is also low in EFA and provides virtually no n-3 fatty acids; therefore malnourished children are at risk for EFA de®-ciency and specially n-3 de®cit. The risk for n-3 de®cit is enhanced if during the recovery period infants are given energy-dense diets high n-6 fatty acids. These diets are usually formulated with vegetable oils that are high in n-6 and low in n-3 fatty acids (corn, sun¯ower, saf¯ower) (Beare-Rogers et al, 1998) .
The breast fed infant will have suf®cient n-6 fatty acids up to 8 and probably up to 12 months of age. If we consider that the n-3 fatty acid supply should be at least 0.5% of energy, the breast fed infant will have suf®cient n-3 EFA from human milk for the ®rst six months of life if the milk volume is 800 ± 1000 mLad and the fat content is 3 ± 4 gadL. If the mother is malnourished, breast milk fat, EFA content and total volume may be reduced; therefore Essential fatty acids R Uauy et al n-3 may be below accepted levels at an earlier age (BeareRogers et al, 1998).
Prevention of chronic disease in relation to EFAs supply
Published experimental work indicates that consumption of terrestial and marine foods with n-3 PUFA has a bene®cial effect on primary and secondary prevention of atherosclerosis, thrombosis and embolism, hypertriglyceridemia, hypertension, autoimmune disease and possibly allergic problems. Bleeding time in the human can be prolonged by 30 ± 50% by supplementing diets with marine oils; platelet aggregation can also be reduced. These effects can be explained by changes in eicosanoid metabolism, shifting it from the arachidonate-derived series 2 metabolites to the EPA-derived series 3 metabolites. Prostaglandins, thromboxanes, leukotrienes, hydroxy fatty acids and lipoxins formed from EPA decrease blood viscosity, platelet aggregation, increase bleeding time, promote vasodilation and insulin sensitivity; in addition they inhibit VLDL formation, cell proliferation, the in¯ammatory and allergic response. Effects are evident with doses ranging from 5 ± 30 g of marine oils or 2 ± 10 g of EPA per day (Uauy & Hoffman, 1991; Innis, 1991; Uauy et al, 1989; Glomset, 1985; Simopoulos, 1991; Galli et al, 1994; Katan, 1995; Bang & Dyerberg, 1972 . Figure 4 summarizes the effects of n-3 polyunsaturated fatty acids inhibiting key steps of the arachidonic acid cascade. Biological effects are dependent on n-6an-3 balance present in membrane phospholipids.
Recent reviews of the vast body of literature accumulated over the past decade are available. The conclusions reached by the reviewers differ based on their biases and on the selection of evidence presented. Simopoulos concludes that`research reports make it increasingly evident that eating o-3 fatty acids can have bene®cial effects on chronic in¯ammatory and cardiovascular diseases' (Simopoulos, 1991; Galli et al, 1994) . A more recent review by Okuyama et al, 1997 from Japan (491 refs) concludes:`It appears to us that an excess of linoleic acid and elevated n-6an-3 ratios in tissues result in over-and unbalanced production of lipid mediators related to arachidonic acid, and that this situation leads to enhanced ischemicain¯ammatory tendencies thereby increasing the incidence of chronic diseases F F F '. It goes on to say:`We suggest that a relative n-3 de®ciency as evidenced by the very high n-6an-3 ratios of plasma lipids might be affecting the behavioral patterns of a signi®cant part of the young generations in industrialized countries.' (Okuyama et al, 1997) . In the opposing camp, the FDA, after an extensive review of this subject as part of its effort to de®ne health claims for food labeling purposes, concluded that most of the documented bene®ts were attributable to the consumption of ®sh as a food and not of marine oil supplementation (FDAaHHS USA, 1991). The verdict is being contended by several groups, amongst them the International Society for Study of Fatty Acids and Lipids (ISSFAL) (Galli et al, 1994) . The issue of whether the bene®cial effects are secondary to n-3 fatty acids or other phenomena associated with the consumption of ®sh will only be settled by prospective randomized controlled clinical trials of speci®c fatty acids, alone or in combination.
Omega-3 PUFA ingestion can have an effect on cardiovascular disease through a variety of mechanisms. The experimental evidence does not permit deciding which of the many putative mechanisms are crucial in determining the effects. Marine oils have antithrombotic effects via modi®cation of platelet aggregation, decreasing vascular adhesiveness, enhancing small vessel relaxation mechanisms, promoting endothelial repair and minimizing in¯am-matory responses in vessel walls (Simopoulos, 1991; Galli et al, 1994; Shimokawa & Vanhoutte, 1988; Leaf & Weber, 1988) . In addition, the risk of heart disease can be indirectly modi®ed by effects on plasma lipoproteins, cholesterol uptake by macrophages, foam cell formation and cell proliferation in vessel walls, blood pressure regulation, changes in cardiac electrophysiologic responses to betamimetics, in the susceptibility to arrhythmias and reduced excitability of cardiac myocytes (Charnock, 1991; Dyerberg et al, 1978; Harris et al, 1988; Knapp & FitzGerald, 1989; . In a prospective randomized controlled trial of ®sh oil as an antiarrythmic agent, patients with spontaneous ventricular premature complexes (VPC) were given ®sh oil (0.9 g EPA 1.5 g DHA) or n-6-rich sun¯ower oil (5 g LA) for 16 weeks. VPCs were signi®cantly reduced in 44% of patients of the ®sh oil group and only in 15% of the sun¯ower oil group (Sellmayer et al, 1995) . The other intervention trial used the Mediterranean diet, rich in LNA sources (2 gad) as a model. Over 600 French patients who survived their ®rst infarcts where randomly assigned to this or the control diet providing only a third of the LNA. The group on the LNA-rich diet had 73% fewer cardiac deaths and non fatal heart attacks than controls (De Lorgeril & Renaud, 1994) . A recent report from the Chicago Western Electric Study to examine the possible bene®t of eating ®sh on risk of dying from coronary heart disease showed in over 1800`healthy' middle aged men that consumption of 35 g or more ®sh per day signi®cantly reduced the cumulative 30 y risk of death from coronary heart disease by 38% and that of myocardial infarction by 44% (Daviglus et al, 1997) .
The mechanism for the antiarrythmic effect has been studied by Leaf' s group who has demonstrated that myocites become less excitable and more resistant to beta adrenergic stimuli due to a modulation of Na channels. Figure 4 Effect of n-3 polyunsaturated fatty acids (n-3 PUFA), inhibiting key steps of the arachidonic acid (n-6) cascade. Phospholipases release arachidonate from membranes which serves to synthesize eicosanoids; n-6 derived eicosanoids formed by cycloxigenase pathway (prostaglandins, prostacyclins, thromboxanes) or lipoxigenase pathway (leukotrienes) are counterbalanced by n-3 PUFA derived eicosanoids. Biological effects are dependent on n-6an-3 balance present in membrane phospholipids.
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The effect is observed with n-6 and n-3 PUFA, but is more prominent in the latter .
Initially it was thought that marine oils had an effect on plasma cholesterol comparable to that of n-6 predominant vegetable oils, however subsequent studies have demonstrated that only n-3 long-chain PUFA lower triglycerides in normal or hyperlipemic subjects (Harris, 1989) . Patients with type V hyperlipidemia have shown dramatic drops in VLDL and triglyceride levels in response to marine oil supplemented diets (Harris, 1989; Nestel et al, 1984) . In contrast, n-6 fatty acids from oil seeds caused a signi®cant rise in triglycerides in this group. The effect on triglycerides appears to be mediated by decreased production and increased fractional catabolic rate of the triglyceride-rich VLDL lipoprotein particle (Nestel et al, 1984) . Small but signi®cant reductions in plasma cholesterol have also been noted after ®sh oil administration in patients with type II heterozygous hypercholesterolemia, while in those with type IV a rise has been noted (Simopoulos, 1991; Nestel et al, 1984; Massarei et al, 1989) . The evidence does not support an LDL cholesterol lowering effect in response to marine oil supplementation in patients with hypercholesterolemia. The response of HDL-cholesterol and apoprotein A in supplementation trials has been variable but the changes, if any, are of minor magnitude. The variability in lipoprotein responses to supplementation in the various trials can be attributed to the differences in overall design, duration of study, patient populations, differences in baseline diets tested, and different oils used. Some studies used ®sh or marine oils while others used concentrated EPA DHA (Simopoulos, 1991; FDAaHHS USA, 1991; Leaf & Weber, 1988; Harris, 1989; Nestel et al, 1984) . Overall these studies suggest a bene®cial effect of ®sh and n-3 LCPUFAs on coronary disease mortality.
Results of studies on the use of marine oil in the prevention of restenosis after coronary angioplasty or bypass surgery were suggestive of bene®cial effects of a combined use of ®sh oil and anticoagulant drugs in reducing thrombotic occlusion of coronary vessels. Furthermore double-blind controlled studies using angiographic evidence for presence of restenosis after coronary angioplasty have failed to disclose the putative bene®ts (Leaf et al, 1994) . A more recent randomized controlled study on graft patency after bypass surgery using 4 gad of ®sh oil in addition to anticoagulants demonstrated a clear bene®t in terms of graft patency 1 y after surgery. The ®sh oil group had only 27% graft occlusion vs 33% in the control group, an inverse relationship between increase in n-3 content of plasma phospholipids and vein graft occlusion was noted (Eritsland et al, 1996) .
EPA and DHA prolong bleeding time and decrease thromboxane A 2 production. These effects seem to be dose dependent but to date no major clinically signi®cant bleeding has been demonstrated in relation to the ingestion of ®sh oils (Lox, 1990) , although one study showed increased incidence of epistaxis when high dose ®sh oil was administered to hypercholesterolemic adolescents (Clarke et al, 1990) . Platelet counts may be affected by large doses of marine oil and platelet half-life may be shortened. The effect on endothelial walls is receiving increasing attention. The production of platelet-derived growth factor is decreased while the formation of endothelium derived relaxing factor is increased (Fox & Dicorleto,1988) . These effects may be important in mediating the antiatherogenic effect of ®sh oil.
Fish oil has also been noted to signi®cantly reduce systolic blood pressure in double-blind crossover controlled studies. Increase in sodium excretion and a decrease in prostaglandin metabolites derived from AA were also found. The lowering of diastolic blood pressure, of greater clinical signi®cance, has been the exception. The interaction of marine oil supplementation and need for antihypertensive drugs has been less explored. A meta analysis conducted by Morris et al (1993) involving a total of over 1300 patients concluded that dietary n-3 fatty acids induce a small but signi®cant reduction in blood pressure in hypertensive but not in normal subjects. This area requires further research before the use of marine oils can be advocated for this purpose (Levinson et al, 1990) .
In adult onset diabetes the effects are mixed since the potentially bene®cial effect on microvessel occlusion and proliferation is offset by a potential increase in glucose output and higher serum glucose levels observed in some studies. Additionally total cholesterol, LDL and apo B serum levels are increased by ®sh oil supplementation in diabetics. On the other hand recent evidence suggests that insulin resistance of adipose tissue may be ameliorated by n-3 and by n-9 fatty acids (Ranaian et al, 1996) . In addition triglyceride levels will commonly decrease with n-3 LCPUFA supplements. A major problem in the interpretation of metabolic effects of PUFAs is the genetic heterogeneity of patients included in these studies; the response may in fact be different within a group that appears to be of a similar phenotype. This may be due to genetic factors which are only beginning to be unraveled. A study in patients with coronary heart disease and normal volunteers demonstrated that hyperinsulinemia, thus insulin resistance, is inversely correlated with long-chain PUFA content of muscle cell membrane phospholipid. The lower the AA and DHA content of membranes the higher the insulin level. This association could be related to dietary EFA content but also both conditions could be determined by a common cause since LCPUFA biosynthesis is affected by insulin activity . No prospective controlled study has addressed this point, thus for now we can only speculate. In terms of mechanisms, it is well known that PUFAs promote fatty acid oxidation and in the case of n-3 LCPUFAs decrease VLDL secretion from the liver. The possibility that speci®c fatty acids promote or inhibit peroxisomal proliferation can be raised given the discovery of peroxisomal proliferation activator receptor (PPAR) and the modulation of its level of expression by speci®c fatty acids (Masataka et al, 1997; Schoonjans et al, 1996) . Increase in saturated fat andaor trans fatty acids relative to n-3 LCPUFA affect PPAR activity thus could potentially adversely affect fatty acid oxidation and prevent the biosynthesis of LCPUFAs by affecting peroxisomes, key site for LCPUFA synthesis from parent EFAs (Martinez, 1996) . The main regulatory actions of PPAR on lipid metabolism are summarized in Table 1 . The putative regulatory effects of dietary fatty acids on mitochondrial and peroxisomal function has led to the proposed hypothesis summarized in Figure 5 . This could be central in explaining the effect of dietary fat on the epidemic of non communicable chronic disease observed in industrialized countries and in some segments of developing societies (Simopoulos, 1994) .
The use of omega-3 marine oils as a natural immunosuppressant has been proposed based on their inhibitory role on arachidonic acid derived products such as prostaglandins and leukotrienes. Several studies on experimental animals have shown that ®sh oil increased survival of animals genetically predisposed to lupus erythematosus and collagen-induced arthritis (Simopoulos, 1991; Galli et al, 1994) . Controlled clinical studies in humans have provided encouraging preliminary results; the effect of ®sh oil are probably mediated by a suppression of LTB 4 and increased LTB 5 formation. IL-1 production is lowered by o-3 LCPUFAs while IL-2 is increased. The role of ®sh oil alone or in combination with antirheumatic medication remains to be determined. Another potential use of marine PUFA being explored is the induction of an immunosuppressed state to prevent the development or progression of type I insulin dependent diabetes in susceptible individuals. Other uses documented by anecdotal evidence or uncontrolled trials include bene®ts in the treatment of migraine, asthma and other allergic conditions and in the control of psoriasis (Simopoulos, 1991; Galli et al, 1994) .
Studies of requirements under disease conditions
Metabolicagenetic disease
There is yet no conclusive evidence of an inherited metabolic defect of DHA andaor AA synthesis causing altered brain or retinal function. However, there is strong evidence that Zellweger and other peroxisomal diseases may be associated with defective formation of C 22 PUFAs. Martinez (1996) and others have provided data from several patients, indicating that in peroxisomal disorders, brain DHA content is extremely low, that plasma and RBC DHA levels are below normal and that the biochemical response of these patients to ®sh oil test material is only partial. Sprecher (1981) has reported that the peroxisomal beta oxidation step necesary for C22 PUFA biosynthesis is restricted in Zellweger patients, thus they can not convert C 24:6, n-3 to C 22:6, n-3. Preliminary results on a limited number of patients studied by Martinez indicate that supplementation with pure DHA is capable of preventing and also of reverting the abnormal motor and mental function associated with these conditions. Concomitant ®broblast studies of these patients provide supportive evidence as to the relative importance of peroxisomal beta oxidation in determining the biochemical and functional consequences of this disease (Martinez, 1996) .
Other potentially adverse health effects The vulnerability of lipid membranes to damage by oxygen free-radicals is directly related to their degree of unsaturation. The double bonds in the carbon chain of the fatty acids are the point of attack for oxygen free radicals. The number of pentadienic units present in a polyunsaturated fatty acid is directly related to its rate of oxidation (Willis, 1984) . Therefore membranes enriched with AA, EPA and DHA are most susceptible to develop oxidative damage. The oxidation process is further catalyzed by the products of oxidation. This self-propagating process may severely affect membrane structure and function unless quenched by proper antioxidants in the membrane. The protection of LCPUFAs is dependent on enzymatic and non-enzymatic systems. Ingestion of high doses of o-3 fatty acids in adults has raised the question of risk for tissue oxidative damage. This effect has been observed in experimental animals by several authors. Moreover, aging appears to be an important factor in the development of this susceptibility. Aged rats, fed ®sh oil show a higher susceptibility to develop tissue lipid peroxidation than young ones (Garrido et al, 1989 (Garrido et al, , 1993 .
Evidence from human studies in young infants suggests that excess dietary PUFAs will increase red cell hemolysis unless appropriate tocopherol supplementation is provided (Oski & Barness, 1967) . Experimental evidence indicates that hyperoxic-induced lung damage may be affected by dietary fat, although the results from mice exposed to oxygen immediately after birth indicate that PUFAs and speci®cally ®sh oil feeding protect from oxygen-induced damage. The proposed explanation for this apparent paradox is that PUFAs in plasma triglycerides may trap free radicals, thus protecting membrane phospholipid PUFAs (Sosenko et al, 1989) . The role of o-3 LCPUFAs in determining the increased susceptibility of the retina to light-induced oxidative damage has been recently studied demonstrating that lower retinal DHA protects rod outer segments from light-induced damage. Tocopherol has been shown to be protective (Bush et al, 1991) . The role of PUFAs and immature antioxidant systems in determining oxygen-induced lung, eye and red cell damage in premature infants is an area of great interest. Increased risk of bronchopulmonary dysplasia and retinopathy of prematurity in preterm infants of Alaskan eskimo background have been observed (Arnold, 1992) . The high o-3 diets and low consumption of green vegetables or other sources of tocopherol may play a role in this phenomenon (Wo & Draper, 1975) .
Increased bleeding is a potentially adverse effect of feeding o-3 fatty acids. The clinical implications of these have not been demonstrated except for anecdotal evidence Figure 5 Speculative mechanisms to explain the effect of dietary fatty acids on b-oxidation and LCPUFA biosynthesis and insulin resistance. These effects could explain the effect of fat on diet related non communicable chronic diseases, obesity, hypertension, non insulin dependent diabetes and hyperlipidemia.
Essential fatty acids R Uauy et al of frequent bruising occurring among ®sh oil eating Greenland eskimos (Dyerberg & Bang, 1979) . Clinical studies have demonstrated increased epistaxis in adolescents given high doses of ®sh oil. On the other hand there is evidence for small non-signi®cant changes in bleeding time in infants given a marine oil supplemented formula (Clarke et al, 1990; Uauy et al, 1994) . The use of marine oils has some potential toxicological risks that can be circumvented by careful processing, storing and preservation of the unsaturated fatty acids.
Conclusions
Infants should be breast fed if at all possible. The fatty acid composition of infant formula should correspond to the amount and proportion of fatty acids contained in mature breast milk from healthy omnivorous women. During weaning and at least until 2 y of age, a child's diet should contain at lest 30 ± 40% of energy from fat and provide similar levels of essential fatty acids as are found in human milk (FAOaWHO 1994) . The n-6 and n-3 fatty acids have critical roles in the membrane structure and as precursors of eicosanoids, which are potent and highly reactive compounds. Since they compete for the same enzymes and have different biological roles, balance between n-6 and n-3 fatty acids in the diet can be of considerable importance.
Desirable intakes of linoleic acid should provide between 4 and 10% of energy (FAOaWHO 1994) . Intakes at the upper end of this range are recommended when intakes of saturated fatty acids and cholesterol are relatively high.
Particular attention must be paid to promoting adequate maternal intakes of essential fatty acids throughout pregnancy and lactation to meet the requirements of fetal and infant development.
ISSFAL suggests an intake of 0.8 ± 1.1 gad of LNA, which is roughly 0.5% of energy; it also suggests 0.3 ± 0.4 gad of n-3 LCPUFAs. To prevent cardiovascular and other non-communicable chronic diseases the recommendation is to eat ®sh 2 ± 3 times a week. Alternatively marine oil 3 ± 4 g per day or n-3 LCPUFAs (EPA DHA) 1.2 g per day or 0.5% of energy have been recommended by the British Nutrition Foundation.
